Is 20-30 % response rate for the ovarian cancer trials in Yale good enough to proceed to Phase III?Surely this would be be their major short medium term hurdle.Interested in your opinions on this.I hold NRT
Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
AIZ Air New Zealand ditches 2030 emissions targets – right as ASIC's Scope 3 reporting changes kick in for FY25